Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.

Brett AS, Ablin RJ.

N Engl J Med. 2011 Nov 24;365(21):1949-51. doi: 10.1056/NEJMp1112191. Epub 2011 Oct 26. No abstract available.

2.

Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.

Schröder FH.

N Engl J Med. 2011 Nov 24;365(21):1953-5. doi: 10.1056/NEJMp1112140. Epub 2011 Oct 26. No abstract available.

3.

One man at a time--resolving the PSA controversy.

McNaughton-Collins MF, Barry MJ.

N Engl J Med. 2011 Nov 24;365(21):1951-3. doi: 10.1056/NEJMp1111894. Epub 2011 Oct 26. No abstract available.

4.

Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.

Kwiatkowski M, Klotz L, Hugosson J, Recker F.

Eur Urol. 2012 Apr;61(4):851-4. doi: 10.1016/j.eururo.2012.01.023. Epub 2012 Jan 24. No abstract available.

PMID:
22285762
5.

The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.

Ablin RJ.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):391-4. doi: 10.1158/1055-9965.EPI-12-0058. Epub 2012 Feb 7. No abstract available.

6.

Preventive Services Task Force recommends against PSA screening after age 75.

Twombly R.

J Natl Cancer Inst. 2008 Nov 19;100(22):1571-3. doi: 10.1093/jnci/djn422. Epub 2008 Nov 11. No abstract available.

7.

The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.

Messing EM, Albertsen P, Andriole GL Jr, Carroll PR, Klein EA.

Urol Oncol. 2012 Jan-Feb;30(1):117-9. doi: 10.1016/j.urolonc.2011.12.010. No abstract available.

PMID:
22243597
9.

Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.

Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire MS, Helfand BT.

Urol Oncol. 2014 Jan;32(1):41.e23-30. doi: 10.1016/j.urolonc.2013.04.013. Epub 2013 Aug 2.

PMID:
23911680
10.

Response to the U.S. Preventative Services Task Force decision on prostate cancer screening.

Makovey I, Stephenson AJ, Haywood S.

Curr Urol Rep. 2013 Jun;14(3):168-73. doi: 10.1007/s11934-013-0318-9.

PMID:
23568623
11.

PSA test not recommended by Canadian Task Force.

Tanday S.

Lancet Oncol. 2014 Dec;15(13):e589. doi: 10.1016/S1470-2045(14)71111-8. Epub 2014 Oct 31. No abstract available.

PMID:
25499287
12.

Psychological research and the prostate-cancer screening controversy.

Arkes HR, Gaissmaier W.

Psychol Sci. 2012 Jun;23(6):547-53. doi: 10.1177/0956797612437428. Epub 2012 May 3.

PMID:
22555966
13.

The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--counterpoint.

Catalona WJ.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):395-7. doi: 10.1158/1055-9965.EPI-12-0059. Epub 2012 Feb 7. No abstract available.

14.

Grading the new US Preventive Services Task Force prostate cancer screening recommendation.

Volk RJ, Wolf AM.

JAMA. 2011 Dec 28;306(24):2715-6. doi: 10.1001/jama.2011.1893. No abstract available.

PMID:
22203540
15.

2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.

Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE.

JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534. No abstract available.

PMID:
22535850
16.

Prostate-specific antigen testing: men's responses to 2012 recommendation against screening.

Squiers LB, Bann CM, Dolina SE, Tzeng J, McCormack L, Kamerow D.

Am J Prev Med. 2013 Aug;45(2):182-9. doi: 10.1016/j.amepre.2013.04.005.

PMID:
23867025
17.

Screening for prostate cancer among men 75 years of age or older.

Barry MJ.

N Engl J Med. 2008 Dec 11;359(24):2515-6. doi: 10.1056/NEJMp0807209. No abstract available.

18.
19.

[U.S. Preventive Services Task Force recommendation or "throwing out the baby with the bath water"].

Recker F.

Urologe A. 2012 Jan;51(1):74-6. doi: 10.1007/s00120-011-2773-6. German. No abstract available.

PMID:
22258377
20.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846

Supplemental Content

Support Center